BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2007
View Archived Issues
Neuren to acquire Hamilton
Read More
TargeGen begins phase II trial of TG-100801 eye drops for AMD
Read More
Positive results for Novogen's antiinflammatory FAIMs in preclinical studies
Read More
Lexicon completes phase I trials of LX-6171 for cognitive disorders
Read More
AVEO's oral antiangiogenic agent heads for phase II evaluation in RCC
Read More
Phase II study data on vicriviroc presented
Read More
Sanofi-aventis and Chugai marketing collaboration in Japan terminated
Read More
New treatment options for cardiovascular diseases discussed in recent patent literature
Read More
New compounds for the treatment of neurological disorders claimed in recent patents
Read More
New antiarthritic drugs claimed in recent patent literature
Read More
Positive interim results from AlphaVax's phase I influenza vaccine trial
Read More
Astion's ASF-1096 recommended orphan drug status by EMEA
Read More
Kyowa Hakko receives MHLW approval for antiepileptic agent KW-6485
Read More
Banyu receives MHLW approval for Singulair fine granule 4 mg for infant bronchial asthma
Read More
Incyte reports second quarter 2007 results
Read More
FDA accepts Fentanyl MDTS IND from Acrux; phase I trial to begin
Read More
Poniard begins phase II trial of intravenous picoplatin with Taxotere and prednisone
Read More
Javelin begins phase III trial of intranasal ketamine for breakthrough cancer pain
Read More
Phase II trial of trastuzumab-DM1 begins; ImmunoGen receives milestone payment
Read More
AlphaVax proceeds with the development of a smallpox vaccine
Read More
Inactivated whole-virion SARS vaccine immunogenic and protective in hamster model
Read More
Erythropoietin modulates emotional responses in humans
Read More
Accentia submits pre-IND application for Revimmune
Read More
YM begins enrollment of phase II trial of nimotuzumab for colorectal cancer
Read More
Positive interim results for OncoGenex and Isis' phase II OGX-011 trial
Read More
Antigenics applies for Oncophage approval for kidney cancer in Russia
Read More
Second FDA approvable letter issued for Trexima
Read More